Georgia Tomaras
Chief, Division of Surgical Sciences
A. Geller Distinguished Professor for Research in Immunology
Professor in Surgery
Professor in Integrative Immunobiology
Professor in Molecular Genetics and Microbiology
Affiliate, Duke Global Health Institute
Dr. Tomaras' overall research program is to understand the cellular and humoral immune response to HIV-1 infection and vaccination that are involved in protection from HIV-1. The research in the Tomaras laboratory centers around three main projects involving 1) antiviral CD8 T cell responses in HIV-1 infection and post vaccination, 2) mucosal and systemic antibody responses to infection and vaccination in both non-human primates and humans and 3) the ontogeny of neutralizing antibodies in HIV-1 infection. Her laboratory is also within the Duke Human Vaccine Institute.
Projects
-
Improved Global HIV-1 Incidence Assay
United States
Publications
-
Lee MJ, Cherrill L-R, Zacharopoulou P, Collins S, Fumagalli M, Falaschetti E, et al. Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial. Lancet HIV. 2026 Aug;13(8):e527–37.King HAD, Subra C, Tourtellott E, Swafford I, Basu S, Rossman M, et al. Rapid and robust immune response boosting with potent, next-generation adjuvant in viral vector-primed primates. J Virol. 2026 Jul 27;e0038926.Jones R, Manickam C, Shrestha S, Kroll K, Woolley G, Bukenya M, et al. Extended hinge length of human IgG3-like antibody enhances early antiviral activity of VRC01 in SHIV-infected rhesus macaques. J Virol. 2026 Jul 22;e0075426.Zhai Y, Ku MW, Yang K, Patil A, Prabhala P, He L, et al. In vitro recapitulation of intramuscular mRNA vaccination with naive and recall antigens using a human lymphoid follicle chip platform. iScience. 2026 Jul 17;29(7):116416.
See more publications at Scholars@Duke